Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Spero Therapeutics, Inc. | 244,147 | reported | 06 Nov 2017 | tx 9+1,854,006−7,399,735 |
| Morphic Holding, Inc. | 1,000 | reported | 05 Mar 2021 | tx 8+2,670,772−2,300,439 |
| Pandion Therapeutics, Inc. | 0 | reported | 01 Apr 2021 | tx 10+110,510−225,702 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 Apr 2021 | TENDER | Pandion Therapeutics, Inc. | 87,764 | 60.00 USD | |
| 01 Apr 2021 | OTHER | Pandion Therapeutics, Inc. | 73,789 | — | deriv |
| 01 Apr 2021 | OTHER | Pandion Therapeutics, Inc. | 28,227 | — | deriv |
| 05 Mar 2021 | PURCHASE | Morphic Holding, Inc. | 1,000 | 70.00 USD | |
| 08 Feb 2021 | GRANT_AWARD | Pandion Therapeutics, Inc. | 73,789 | 0.00 USD | deriv |
| 21 Jul 2020 | PURCHASE | Pandion Therapeutics, Inc. | 1,450 | 18.00 USD | first after silence |
| 21 Jul 2020 | CONVERSION | Pandion Therapeutics, Inc. | 7,044 | — | |
| 17 Jul 2020 | GRANT_AWARD | Pandion Therapeutics, Inc. | 3,806 | 0.00 USD | deriv |
| 17 Jul 2020 | GRANT_AWARD | Pandion Therapeutics, Inc. | 13,935 | 0.00 USD | deriv |
| 17 Jul 2020 | GRANT_AWARD | Pandion Therapeutics, Inc. | 10,486 | 0.00 USD | deriv |
| 21 Jul 2020 | CONVERSION | Pandion Therapeutics, Inc. | 35,922 | 0.00 USD | deriv |
| 18 Jun 2020 | GRANT_AWARD | Morphic Holding, Inc. | 12,000 | 0.00 USD | deriv |
| 01 Aug 2019 | GRANT_AWARD | Morphic Holding, Inc. | 24,000 | 0.00 USD | deriv |
| 01 Jul 2019 | CONVERSION | Morphic Holding, Inc. | 1,469,950 | — | |
| 01 Jul 2019 | CONVERSION | Morphic Holding, Inc. | 830,489 | — | |
| 01 Jul 2019 | PURCHASE | Morphic Holding, Inc. | 333,333 | 15.00 USD | first after silence |
| 01 Jul 2019 | CONVERSION | Morphic Holding, Inc. | 1,469,950 | — | deriv |
| 01 Jul 2019 | CONVERSION | Morphic Holding, Inc. | 830,489 | — | deriv |
| 06 Nov 2017 | PURCHASE | Spero Therapeutics, Inc. | 428,571 | 14.00 USD | |
| 06 Nov 2017 | CONVERSION | Spero Therapeutics, Inc. | 606,024 | — | |
| 06 Nov 2017 | CONVERSION | Spero Therapeutics, Inc. | 328,992 | — | |
| 06 Nov 2017 | CONVERSION | Spero Therapeutics, Inc. | 246,272 | — | |
| 06 Nov 2017 | CONVERSION | Spero Therapeutics, Inc. | 244,147 | — | |
| 06 Nov 2017 | CONVERSION | Spero Therapeutics, Inc. | 1,250,000 | 0.00 USD | deriv |
| 06 Nov 2017 | CONVERSION | Spero Therapeutics, Inc. | 1,483,784 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 21 Jul 2020.